These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1333012)

  • 1. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists.
    Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B
    J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists.
    Labaudinière R; Hendel W; Terlain B; Cavy F; Marquis O; Dereu N
    J Med Chem; 1992 Nov; 35(23):4306-14. PubMed ID: 1333011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists.
    Dillard RD; Hahn RA; McCullough D; Carr FP; Rinkema LE; Roman CR; Fleisch JH
    J Med Chem; 1991 Sep; 34(9):2768-78. PubMed ID: 1654427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.
    Herron DK; Goodson T; Bollinger NG; Swanson-Bean D; Wright IG; Staten GS; Thompson AR; Froelich LL; Jackson WT
    J Med Chem; 1992 May; 35(10):1818-28. PubMed ID: 1316967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
    Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
    J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain.
    Gapinski DM; Mallett BE; Froelich LL; Jackson WT
    J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-[(omega-arylalkyl)thienyl]alkanoic acids: from specific LTA4 hydrolase inhibitors to LTB4 receptor antagonists.
    Labaudinière R; Hilboll G; Leon-Lomeli A; Terlain B; Cavy F; Parnham M; Kuhl P; Dereu N
    J Med Chem; 1992 Aug; 35(17):3170-9. PubMed ID: 1324316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.
    Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL
    Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist.
    Silbaugh SA; Stengel PW; Cockerham SL; Roman CR; Saussy DL; Spaethe SM; Goodson T; Herron DK; Fleisch JH
    Eur J Pharmacol; 1992 Nov; 223(1):57-64. PubMed ID: 1335877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146.
    Fretland DJ; Widomski DL; Anglin CP; Penning TD; Yu S; Djuric SW
    Inflammation; 1993 Jun; 17(3):353-60. PubMed ID: 8392493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
    Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
    J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
    J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of leukotriene B4 analogs: inhibition of guinea pig eosinophil migration in vitro by the 2,6-disubstituted pyridine analogs U-75,302 and U-75,485.
    Taylor BM; Crittenden NJ; Bruden MN; Wishka DG; Morris J; Richards IM; Sun FF
    Prostaglandins; 1991 Sep; 42(3):211-24. PubMed ID: 1664113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.